Clinical Trial Update: A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study comparing AZD5718 oral suspension to an immediate-release tablet to determine relative bioavailability, using rosuvastatin as a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• AZD5718 (AZD5718)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: High Risk Coronary Artery Disease | Phase 1 | Status: COMPLETED